VDR Gene: Why Some People Need More Vitamin D Than Others

TL;DR: The VDR gene encodes the receptor that translates vitamin D into cellular action across more than 1,000 target genes. Key variants like FokI (rs2228570) produce receptors with different transcriptional activity — the less active form is 1.7 times weaker. This helps explain why nearly half the world's population remains vitamin D insufficient despite similar sun exposure and supplementation, and why one-size-fits-all dosing fails for many people.

Disclaimer: This article is for educational purposes. It does not constitute medical advice. Consult a healthcare professional for personalized guidance.

Roughly 1 billion people worldwide have vitamin D deficiency. A pooled analysis of 7.9 million participants across 81 countries found that 47.9% had serum 25-hydroxyvitamin D levels below 50 nmol/L — the threshold most clinical guidelines use for insufficiency (Cashman et al., Annals of the New York Academy of Sciences, 2023). The standard advice is straightforward: more sun, more supplements.

But there is a problem with standard advice. Two people with the same skin tone, living at the same latitude, taking the same supplement dose, can end up with meaningfully different vitamin D levels — and even more importantly, different cellular responses to whatever vitamin D they have. The missing variable is genetics, specifically the VDR gene. The VDR gene vitamin D connection is one of the clearest examples in nutrigenomics of why personalized approaches outperform population averages. Your VDR genotype affects not only how much vitamin D circulates in your blood but how effectively your cells can use it.

What Is the VDR Gene? Your Body's Vitamin D Interpreter

The VDR gene sits on chromosome 12q13.11 and encodes the vitamin D receptor — a nuclear transcription factor that serves as the primary mediator of vitamin D's biological effects. When the active form of vitamin D (1,25-dihydroxyvitamin D, also called calcitriol) binds this receptor, the VDR forms a heterodimer with the retinoid X receptor (RXR) and attaches to vitamin D response elements (VDREs) in the promoter regions of target genes. This complex regulates more than 1,000 genes involved in calcium absorption, bone metabolism, immune regulation, and cell proliferation (NCBI Gene).

Vitamin D receptor (VDR): a nuclear transcription factor encoded by the VDR gene on chromosome 12 that, when activated by calcitriol, regulates more than 1,000 target genes controlling calcium homeostasis, immune function, and cell growth.

Think of it this way: vitamin D in your blood is the signal; the VDR protein is the antenna that receives it. You can have excellent signal strength — high circulating 25(OH)D levels — but if your antenna is less sensitive, the cellular response will be weaker. This is why blood levels alone do not tell the complete story of your vitamin D status. Someone with a highly active VDR variant may get more biological benefit from the same circulating vitamin D than someone with a less active variant. Understanding this distinction is a practical example of why comprehensive DNA analysis adds context that a single blood test cannot provide.

The VDR protein is expressed in nearly every tissue in the body — not just bone and intestine (the classic vitamin D targets) but also immune cells, brain, muscle, pancreas, and skin. This wide distribution explains why vitamin D deficiency has been associated with conditions far beyond rickets, from autoimmune diseases to cardiovascular risk.

The Four Key VDR Variants: How Your Vitamin D Receptor Differs

Four single nucleotide polymorphisms in the VDR gene have been studied extensively across dozens of populations and disease contexts. Each affects VDR function through a different mechanism.

FokI (rs2228570) — The One That Changes the Protein

FokI is the most functionally distinct VDR polymorphism. It is the only one that alters the actual structure of the VDR protein.

The polymorphism is a T-to-C transition at the translation initiation site in exon 2 of the VDR gene. This single nucleotide change determines which of two start codons the ribosome uses, producing one of two protein variants: the C allele (commonly called the "F" allele) produces a shorter VDR protein of 424 amino acids, while the T allele (the "f" allele) produces a longer protein of 427 amino acids (Nature Scientific Reports, 2020).

Three amino acids may sound trivial. It is not. The shorter 424-amino-acid protein interacts more efficiently with transcription factor IIB (TFIIB), resulting in 1.7-fold higher transcriptional activity compared to the longer variant. In practical terms, the F allele produces a VDR that is substantially better at translating vitamin D into gene regulation.

The clinical significance follows logically. A systematic review and meta-analysis found that individuals with the FokI FF genotype showed a significantly better response to vitamin D supplementation (p < 0.001) compared to those carrying the f allele (Usategui-Martin et al., Nutrients, 2022). Separately, the ff genotype has been associated with a 1.78 times higher prevalence of type 2 diabetes in a Brazilian population study (PMC, 2024).

BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236) — The mRNA Stability Trio

The other three major VDR polymorphisms — BsmI, ApaI, and TaqI — work through a different mechanism. Located in the 3' region of the VDR gene (intron 8 for BsmI and ApaI, exon 9 for TaqI), these variants do not change the amino acid sequence of the VDR protein. Instead, they influence the stability of VDR messenger RNA by affecting polyadenylation signals that determine how long the mRNA survives before degradation.

More stable mRNA means more VDR protein gets produced. Less stable mRNA means less receptor is available, even though each individual receptor molecule functions normally. BsmI and TaqI are in strong linkage disequilibrium, meaning they tend to be inherited together.

The TaqI polymorphism shows the clearest supplementation signal: the variant allele (Tt or tt genotypes) was associated with a better response to vitamin D supplementation (p = 0.02) in the same meta-analysis that identified FokI's effect. BsmI and ApaI, by contrast, did not show a statistically significant modification of supplementation response in pooled analyses, though individual studies have reported associations in specific populations (Usategui-Martin et al., Nutrients, 2022).

Single nucleotide polymorphism (SNP): a variation at a single position in a DNA sequence, representing the most common type of genetic variation. SNPs in genes like VDR can affect protein structure, mRNA stability, or gene regulation — read more in our guide to SNPs.

How VDR Variants Affect Your Vitamin D Needs

Supplementation Response Varies by Genotype

The meta-analysis by Usategui-Martin and colleagues (2022) pulled together data from multiple randomized controlled trials examining how VDR genotype modifies the response to vitamin D supplementation. The findings were clear: the same supplement dose produces different outcomes depending on which VDR variants you carry.

People with the FokI FF genotype — the shorter, more active receptor — achieved significantly higher serum 25(OH)D levels after supplementation than those with the Ff or ff genotypes. The TaqI variant showed a similar pattern: carriers of the t allele responded better. These are not subtle differences. They represent a biological explanation for why some individuals remain deficient despite following standard supplementation guidelines, while others reach adequate levels easily.

This has direct practical implications. Current vitamin D supplementation recommendations are population-level estimates — typically 600-800 IU daily for adults, with higher doses for those at risk of deficiency. But if your VDR genotype makes you a less efficient responder, the standard dose may be insufficient. A person carrying the ff FokI genotype may require monitoring and dose adjustment — guided by a healthcare provider — that someone with the FF genotype does not need.

Beyond Blood Levels — Why VDR Genotype Matters Even When Numbers Look Normal

There is a subtlety here that standard blood tests miss entirely. Serum 25(OH)D measures how much vitamin D is circulating — the raw material. It does not measure how effectively that vitamin D is being used at the cellular level. A person with the ff FokI genotype may show an adequate 25(OH)D level on a blood test while their cells are extracting less biological value from each molecule because their VDR is 1.7 times less transcriptionally active.

This is the difference between having fuel and having an efficient engine. Both matter. Standard vitamin D testing measures the fuel tank. VDR genotyping tells you about the engine. This is where the concept of nutrigenomics — understanding gene-nutrient interactions — moves from theoretical interest to practical value. Knowing your VDR genotype does not replace a 25(OH)D blood test; it adds a layer of interpretation that the blood test alone cannot provide.

VDR Gene, Disease Risk, and What the Evidence Actually Shows

Bone Health and Osteoporosis

The connection between VDR and bone health is the most studied and most intuitive — vitamin D's best-known role is calcium absorption and bone mineralization. A meta-analysis by Gao and colleagues (2020) found that the ApaI, BsmI, and TaqI polymorphisms were significantly associated with osteoporosis risk in Caucasian populations. In Asian populations, BsmI and FokI showed significant associations (European Journal of Medical Research).

The population specificity is important. A VDR variant that increases osteoporosis risk in one ethnic group may show no association in another. This reflects differences in allele frequencies, linkage disequilibrium patterns, dietary calcium intake, sun exposure, and other environmental modifiers. It is a reminder that genetic risk is always contextual.

Immune Function and Autoimmune Disease

The VDR is expressed in most immune cells — T cells, B cells, macrophages, and dendritic cells. This expression pattern explains why vitamin D deficiency and VDR variants have been linked to immune-related conditions that extend well beyond bone health.

For tuberculosis susceptibility, meta-analyses have found that the BsmI polymorphism is associated with decreased TB risk in Asian populations, while FokI ff homozygosity is associated with increased risk, particularly in East and Southeast Asian populations (PMC, 2023). For multiple sclerosis, the TaqI polymorphism has been associated with MS susceptibility in meta-analyses, while ApaI associations vary by population. The ApaI A allele and AA genotype appear to be shared risk factors across multiple autoimmune conditions, including MS, Behcet's disease, and systemic lupus erythematosus (Colombini et al., International Journal of Molecular Sciences, 2023).

These associations are real but modest. VDR variants are one piece of a complex puzzle — they increase or decrease susceptibility, but they do not determine outcomes. Environmental factors, other genetic variants, and the interplay between them all contribute. Honesty about effect sizes matters: a VDR polymorphism is a data point in a risk profile, not a diagnosis. As with other nutrigenomic markers like MTHFR or FTO, the value lies in context, not in isolation.

What We Do Not Know Yet

Several important questions remain open. The interaction between VDR genotype and variables like latitude, skin pigmentation, dietary patterns, and gut microbiome composition is not fully mapped. Most studies have been conducted in European or East Asian populations, leaving significant gaps for African, South Asian, and Latin American populations. And the effect sizes for individual VDR variants on disease risk, while statistically significant in meta-analyses, are often modest — odds ratios typically between 1.2 and 2.0.

The honest assessment: VDR genotyping provides useful information about vitamin D metabolism and supplementation response, particularly for FokI and TaqI variants. Its value for predicting specific disease outcomes is more limited and population-dependent. This is a forecast, not a verdict — information that helps you calibrate your strategy, not a sentence that determines your fate.

FAQ — VDR Gene and Vitamin D

Does the VDR gene cause vitamin D deficiency? No. VDR variants do not cause deficiency — they modify how efficiently your body uses the vitamin D it has. Deficiency is primarily driven by insufficient sun exposure, dietary intake, or absorption issues. However, certain VDR genotypes (particularly FokI ff) make it harder to achieve adequate cellular vitamin D activity even when blood levels appear normal.

Should I get tested for VDR gene variants? Testing is available through SNP genotyping panels that include rs2228570 (FokI), rs1544410 (BsmI), rs7975232 (ApaI), and rs731236 (TaqI). The most clinically actionable variants are FokI and TaqI, given their demonstrated effects on supplementation response. Services like DeepDNA include VDR variants as part of a broader nutrigenomic profile alongside dozens of other gene-nutrient interactions.

Can I compensate for a less active VDR variant? Evidence suggests that individuals with less active VDR variants may benefit from higher supplementation doses and more frequent monitoring of serum 25(OH)D levels. Some research also indicates that the active form of vitamin D (calcitriol) can upregulate VDR expression itself, creating a positive feedback loop. However, dose adjustments should be made with a healthcare provider, as vitamin D toxicity is possible at very high doses.

How common are VDR gene variants? VDR variants are extremely common. The FokI f allele frequency ranges from approximately 30% to 50% depending on the population, meaning a significant proportion of people carry at least one copy of the less active variant. BsmI, ApaI, and TaqI variant allele frequencies similarly vary across ethnic groups but are all common polymorphisms, not rare mutations.

The Antenna Analogy — A DeepDNA Perspective

The VDR story reinforces a principle we see across nutrigenomics: the same input produces different outputs depending on your genetic hardware. Vitamin D is the signal; VDR is the antenna. Some people have high-gain antennas — the FokI FF genotype, with its 1.7-fold greater transcriptional activity. Others have standard antennas that work fine but require a stronger signal to achieve the same cellular response.

Knowing your antenna quality changes your strategy. If you have a high-gain antenna, standard recommendations may be sufficient. If your antenna is less sensitive, you might need to optimize your signal — through adjusted supplementation, more deliberate sun exposure, or more frequent monitoring. This is not about genetic determinism. It is about using available information to make smarter decisions, the same way you would check a weather forecast before deciding whether to carry an umbrella.

The VDR gene is one data point among many in a nutrigenomic profile. Paired with information about MTHFR variants (folate metabolism), FTO variants (weight management), and CYP1A2 variants (caffeine metabolism), it contributes to a picture of how your specific biology interacts with your environment and choices. That picture does not tell you what will happen. It tells you what is more likely, and what you can do about it.

Curious about your VDR genotype and vitamin D metabolism? DeepDNA's nutrigenomic analysis reports on VDR alongside dozens of other gene-nutrient interactions — turning raw genetic data into personalized, actionable insights.